清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Epstein–Barr Virus‐Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study

医学 移植 多中心研究 回顾性队列研究 肾移植 爱泼斯坦-巴尔病毒 肾 病毒 病理 病毒学 内科学 随机对照试验
作者
Laurène Tardieu,Dany Anglicheau,Rébecca Sberro‐Soussan,Mathilde Lemoine,Léonard Golbin,Ophélie Fourdinier,Julie Bruneau,Marina Charbit,Tchao Méatchi,Jean‐Emmanuel Serre,Moglie Le Quintrec,Alexandre Karras,É. Thervet,Hélène Lazareth
出处
期刊:Clinical transplantation [Wiley]
卷期号:38 (8): e15424-e15424 被引量:2
标识
DOI:10.1111/ctr.15424
摘要

ABSTRACT Background Epstein–Barr virus (EBV) is a herpesvirus linked to nine different human tumors and lymphoproliferative disorders. Immunosuppression promotes EBV‐driven malignancies. The most frequent EBV‐induced malignancies are lymphomas and nasopharyngeal carcinoma. By promoting smooth muscle proliferation, EBV can induce EBV‐associated smooth muscle tumors (EBV‐SMT). EBV‐SMT is a rare oncological entity for which no current guideline for diagnosis or management exists. Data on posttransplant EBV‐SMT (PT‐SMT) are scarce in kidney transplant recipients. Methods We conducted a national multicentric retrospective study and collected cases among transplantation centers in France. Kidney transplant recipients experiencing histologically proven PT‐SMT were included. We collected data on demographic characteristics of patient, history of kidney transplantation, history of PT‐SMT, evolution of graft function, and patient survival. Results Eight patients were included. The median age at PT‐SMT diagnosis was 31 years (range 6.5–40). PT‐SMT occurred after a median delay of 37.8 months after transplantation (range 6–175). PT‐SMT management consisted in immunosuppressive regimen minimization in all patients. Introduction of mTOR inhibitors was performed in two patients. Four patients (50%) needed chemotherapy. Surgical resection was performed in four patients. At last follow‐up after PT‐SMT diagnosis (median 33 months (range 17–132)), five patients were considered in complete remission, and two patients had died. Two patients experienced graft rejection; two resumed dialysis (25%). All patients with available data presented with impaired graft function at last follow‐up. Conclusion PT‐SMT is a subacute and progressive disease during kidney transplantation. Even if the risk of developing PT‐SMT is low in kidney transplant recipients (0.07% in our cohort), PT‐SMT is associated with significant graft loss, possibly due to reduced immunosuppression. Developing guidelines could help transplantation teams better manage these patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李先生完成签到 ,获得积分10
3秒前
7秒前
平常觅风完成签到,获得积分10
8秒前
幽默的迎天完成签到,获得积分10
10秒前
11秒前
伯赏松思完成签到,获得积分10
12秒前
在水一方完成签到,获得积分0
17秒前
田様的应助被Jannatul采纳,获得10
18秒前
19秒前
名字有点甜诶完成签到 ,获得积分10
28秒前
28秒前
年轻新晴完成签到,获得积分10
29秒前
29秒前
34秒前
Jannatul发布了新的文献求助10
35秒前
Research完成签到 ,获得积分10
38秒前
39秒前
龙弟弟完成签到 ,获得积分10
44秒前
49秒前
体贴的小霜完成签到,获得积分10
49秒前
魔幻雅柔完成签到,获得积分10
55秒前
Zephyr完成签到 ,获得积分10
56秒前
58秒前
清新的方盒完成签到 ,获得积分10
1分钟前
1分钟前
Jannatul完成签到,获得积分10
1分钟前
1分钟前
pericles发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
ubless607的应助被科研通管家采纳,获得10
1分钟前
怕黑的驳完成签到,获得积分10
1分钟前
老猫322完成签到 ,获得积分10
1分钟前
1分钟前
英俊的傲珊完成签到,获得积分10
1分钟前
1分钟前
小橙子完成签到 ,获得积分10
1分钟前
qaplay完成签到 ,获得积分0
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185496
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834498
捐赠科研通 7783092
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481346